The company has, nevertheless, accepted one cannabis-derived drug product: Epidiolex (cannabidiol), and three synthetic cannabis-related drug merchandise: Marinol (dronabinol), Syndros (dronabinol), and Cesamet (nabilone). FDA has authorised Epidiolex, which accommodates a purified type of the drug substance cannabidiol (CBD) for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients 2 years
